These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30992052)

  • 1. Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat.
    Li C; Mousseau G; Valente ST
    Epigenetics Chromatin; 2019 Apr; 12(1):23. PubMed ID: 30992052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.
    Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.
    Mediouni S; Chinthalapudi K; Ekka MK; Usui I; Jablonski JA; Clementz MA; Mousseau G; Nowak J; Macherla VR; Beverage JN; Esquenazi E; Baran P; de Vera IMS; Kojetin D; Loret EP; Nettles K; Maiti S; Izard T; Valente ST
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.
    Kessing CF; Nixon CC; Li C; Tsai P; Takata H; Mousseau G; Ho PT; Honeycutt JB; Fallahi M; Trautmann L; Garcia JV; Valente ST
    Cell Rep; 2017 Oct; 21(3):600-611. PubMed ID: 29045830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.
    Mediouni S; Kessing CF; Jablonski JA; Thenin-Houssier S; Clementz M; Kovach MD; Mousseau G; de Vera IMS; Li C; Kojetin DJ; Evans DT; Valente ST
    FASEB J; 2019 Jul; 33(7):8280-8293. PubMed ID: 31021670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
    Li C; Mori L; Valente ST
    J Infect Dis; 2021 Feb; 223(12 Suppl 2):46-53. PubMed ID: 33586776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A.
    Rice AP
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency.
    Rafati H; Parra M; Hakre S; Moshkin Y; Verdin E; Mahmoudi T
    PLoS Biol; 2011 Nov; 9(11):e1001206. PubMed ID: 22140357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Didehydro-Cortistatin A: a new player in HIV-therapy?
    Mousseau G; Valente ST
    Expert Rev Anti Infect Ther; 2016; 14(2):145-8. PubMed ID: 26581953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter.
    Mahmoudi T; Parra M; Vries RG; Kauder SE; Verrijzer CP; Ott M; Verdin E
    J Biol Chem; 2006 Jul; 281(29):19960-8. PubMed ID: 16687403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice.
    Mediouni S; Jablonski J; Paris JJ; Clementz MA; Thenin-Houssier S; McLaughlin JP; Valente ST
    Curr HIV Res; 2015; 13(1):64-79. PubMed ID: 25613133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription.
    Easley R; Carpio L; Dannenberg L; Choi S; Alani D; Van Duyne R; Guendel I; Klase Z; Agbottah E; Kehn-Hall K; Kashanchi F
    Virology; 2010 Sep; 405(2):322-33. PubMed ID: 20599239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
    Jin H; Li D; Lin MH; Li L; Harrich D
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.